Pharmaceutical Export to Africa

Aarogya Formulations of Ahmedabad — WHO-GMP generics cleared and entering three African markets.

₹5.8CrFirst-year sales

3Markets registered

90dUntil export-ready

14SKUs with dossiers

Overview

In pharma exports, compliance remains the offering

Aarogya made quality generics yet had never registered outside India. Nigeria's NAFDAC, Kenya's PPB and Tanzania's TMDA each demanded dossiers in different formats — a maze that had already eaten 18 months of solo effort.

Harborline's life-sciences unit drafted parallel dossiers, appointed local agents, and phased the filings so the first clearance (Kenya, day 74) funded the rest.

Blister-packed generic medicines ready for dispatch

Challenge

Three regulators, three manuals

Absent stability data, no agents in Nairobi or Lagos, and cold-chain needs for two delicate lines beyond their forwarder's scope. Every delay drained working capital.

Approach

Parallel filings, single desk

Weeks 1–4: dossier gap review; stability and CoA records completed alongside the plant QA team.
Month 2: dossiers filed in Kenya, Tanzania and Nigeria through vetted local agents.
Month 3: initial approvals; distributor pacts inked across Nairobi and Dar es Salaam.
Ongoing: qualified 2–8 °C shippers plus data loggers on each cold consignment.

Outcome

₹5.8 crore spread across three markets

Fourteen SKUs cleared, six distributors trading, with repeat orders above 70%. Nigeria's approval landed in month five, unlocking fresh revenue.

“With Harborline we stood export-ready inside 90 days, and their network across Kenya and Nigeria is genuinely exceptional.” — Dr. Deepak Vora, Director

Related Work